Literature DB >> 10072414

Treatment of attention-deficit-hyperactivity disorder.

J Elia1, P J Ambrosini, J L Rapoport.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072414     DOI: 10.1056/NEJM199903113401007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  54 in total

Review 1.  Evidence based management of attention deficit hyperactivity disorder.

Authors:  J P Guevara; M T Stein
Journal:  BMJ       Date:  2001-11-24

Review 2.  Attention deficit hyperactivity disorder.

Authors:  J P Guevara; M T Stein
Journal:  West J Med       Date:  2001-09

3.  Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use.

Authors:  C Poulin
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

Review 4.  Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder.

Authors:  B Vitiello
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

5.  Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK.

Authors:  Hershel Jick; James A Kaye; Corri Black
Journal:  Br J Gen Pract       Date:  2004-05       Impact factor: 5.386

6.  Comparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder.

Authors:  Robert L Findling; Declan Quinn; Simon J Hatch; Sara J Cameron; Heleen H DeCory; Michael McDowell
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-06-21       Impact factor: 4.785

7.  Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.

Authors:  Moon-Soo Lee; Jae-Won Yang; Young-Hoon Ko; Changsu Han; Seung-Hyun Kim; Min-Soo Lee; Sook-Haeng Joe; In-Kwa Jung
Journal:  Child Psychiatry Hum Dev       Date:  2007-08-31

8.  Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Authors:  John S Markowitz; Arthur B Straughn; Kennerly S Patrick; C Lindsay DeVane; Linda Pestreich; James Lee; Yanfeng Wang; Rafael Muniz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.

Authors:  Mark A Stein; Irwin Waldman; Jeffrey Newcorn; Jeffrey Bishop; Rick Kittles; Edwin H Cook
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-09       Impact factor: 2.576

10.  Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.

Authors:  Heleen Suzanne Soeters; Fleur Margaret Howells; Vivienne Ann Russell
Journal:  Metab Brain Dis       Date:  2008-07-30       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.